Yahoo
NasdaqGS - Nasdaq Real Time Price USD

Cytek Biosciences, Inc. (CTKB)

6.13 -0.17 (-2.70%)
At close: October 30 at 4:00:01 PM EDT
6.13 0.00 (0.00%)
After hours: October 30 at 4:33:26 PM EDT
Trade CTKB on Coinbase

Valuation Measures

Currency in USD Download
Current 6/30/2026 3/31/2026 12/31/2025 9/30/2025 6/30/2025
Market Cap
796.80M 572.10M 561.76M 645.72M 441.47M 430.64M
Enterprise Value
561.25M 337.36M 323.98M 408.81M 203.12M 180.93M
Trailing P/E
-- -- -- -- -- --
Forward P/E
-- -- -- -- -- --
PEG Ratio (current)
-- -- -- -- -- --
Price/Sales
3.81 -- -- -- -- --
Price/Book
2.47 -- -- -- -- --
Enterprise Value/Revenue
2.72 1.65 1.61 2.08 1.04 0.92
Enterprise Value/EBITDA
-- -- -- -- -- --
6/30/2025 - 7/23/2021

Upgrade to begin using 40 years of earnings data and get so much more.

Build financial models with decades of earnings stats, ratios, and valuation data — all exportable — to power your trade ideas.

Upgrade

Financial Highlights

Fiscal Year

Fiscal Year Ends 12/31/2025
Most Recent Quarter (mrq) 6/30/2026

Profitability

Profit Margin -38.98%
Operating Margin (ttm) -29.50%

Management Effectiveness

Return on Assets (ttm) -6.31%
Return on Equity (ttm) -23.04%

Income Statement

Revenue (ttm) 206.71M
Revenue Per Share (ttm) 1.61
Quarterly Revenue Growth (yoy) 5.60%
Gross Profit (ttm) 107.23M
EBITDA -39.76M
Net Income Avi to Common (ttm) -80.58M
Diluted EPS (ttm) -0.62
Quarterly Earnings Growth (yoy) --

Balance Sheet

Total Cash (mrq) 262M
Total Cash Per Share (mrq) 2.02
Total Debt (mrq) 26.46M
Total Debt/Equity (mrq) 8.22%
Current Ratio (mrq) 4.48
Book Value Per Share (mrq) 2.48

Cash Flow Statement

Operating Cash Flow (ttm) -6.04M
Levered Free Cash Flow (ttm) 9.3M

Trading Information

Stock Price History

Beta (5Y Monthly) 1.16
52 Week Change 3 55.58%
S&P 500 52-Week Change 3 10.63%
52 Week High 3 6.34
52 Week Low 3 3.31
50-Day Moving Average 3 5.28
200-Day Moving Average 3 4.65

Share Statistics

Avg Vol (3 month) 3 1.21M
Avg Vol (10 day) 3 1.18M
Shares Outstanding 5 129.98M
Implied Shares Outstanding 6 129.98M
Float 8 102.94M
% Held by Insiders 1 8.47%
% Held by Institutions 1 62.84%
Shares Short (10/15/2026) 4 4.41M
Short Ratio (10/15/2026) 4 2.67
Short % of Float (10/15/2026) 4 4.29%
Short % of Shares Outstanding (10/15/2026) 4 3.39%
Shares Short (prior month 9/15/2026) 4 5.24M

Dividends & Splits

Forward Annual Dividend Rate 4 --
Forward Annual Dividend Yield 4 0.00%
Trailing Annual Dividend Rate 3 0.00
Trailing Annual Dividend Yield 3 0.00%
5 Year Average Dividend Yield 4 --
Payout Ratio 4 0.00%
Dividend Date 3 --
Ex-Dividend Date 4 --
Last Split Factor 2 --
Last Split Date 3 --

Footnotes

  • 1 Data provided by Refinitiv.
  • 2 Data provided by EDGAR Online.
  • 3 Data derived from multiple sources or calculated by Yahoo Finance.
  • 4 Data provided by Morningstar, Inc.
  • 5 Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.
  • 6 Implied Shares Outstanding of common equity, assuming the conversion of all convertible subsidiary equity into common.
  • 7 EBITDA is calculated by S&P Global Market Intelligence using methodology that may differ from that used by a company in its reporting.
  • 8 A company's float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which may not be publicly traded.

Abbreviation Guide

  • mrq  =  Most Recent Quarter
  • ttm  =  Trailing Twelve Months
  • yoy  =  Year Over Year
  • lfy  =  Last Fiscal Year
  • fye  =  Fiscal Year Ending

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: